Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125965722 | 12596572 | 2 | F | 20091215 | 20160722 | 20160727 | 20160729 | EXP | JP-ROCHE-1607871 | ROCHE | ARUGA T, KUROI [****] AND SHINICHIRO HORIGUCHI, KOTOWARISHA] GOTO, TOMOYUKI ARIGA, YAMASHITA YEAR ET AL. P2 -2-71 ONE EXAMPLE (NEGATIVE PRIMARY ORIGIN HER2 WHERE T-DM1 WAS EFFECTIVE AND RELAPSE NEST HER2 POSITIVE MAMMARY CARCINOMA). THE 13TH JAPANESE MEDICAL PRACTICE ONCOLOGY ASSOCIATION SCIENCE MEETING (2015.7.16,17,18) SAPPORO CITY, HOKKAIDO 2015 JUL;:-. | 9.00 | DEC | F | Y | 0.00000 | 20160729 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125965722 | 12596572 | 1 | PS | KADCYLA | ADO-TRASTUZUMAB EMTANSINE | 1 | Intravenous drip | 125427 | 3.6 | MG/KG | SOLUTION FOR INFUSION | Q3W | |||||||
| 125965722 | 12596572 | 2 | SS | KADCYLA | ADO-TRASTUZUMAB EMTANSINE | 1 | Intravenous drip | FREQUENCY IS UNCERTAIN?DOSE INTERRUPTED IN //2016 | 125427 | 148.8 | MG | SOLUTION FOR INFUSION | |||||||
| 125965722 | 12596572 | 3 | SS | KADCYLA | ADO-TRASTUZUMAB EMTANSINE | 1 | Intravenous drip | DOSAGE IS UNCERTAIN | 125427 | SOLUTION FOR INFUSION | |||||||||
| 125965722 | 12596572 | 4 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous drip | Y | 103792 | 4 | MG/KG | SOLUTION FOR INFUSION | QD | ||||||
| 125965722 | 12596572 | 5 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous drip | Y | 103792 | 77 | MG | SOLUTION FOR INFUSION | /wk | ||||||
| 125965722 | 12596572 | 6 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous drip | Y | 103792 | 77 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 125965722 | 12596572 | 7 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous drip | Y | 103792 | 85 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 125965722 | 12596572 | 8 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous drip | Y | 103792 | 163 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 125965722 | 12596572 | 9 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous drip | Y | 103792 | 213 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 125965722 | 12596572 | 10 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous drip | Y | 103792 | 216 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 125965722 | 12596572 | 11 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous drip | Y | 103792 | 216 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 125965722 | 12596572 | 12 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous drip | DOSAGE IS UNCERTAIN.?MOST RECENT DOSE ON 08/JAN/2010. | Y | 0 | 100 | MG | |||||||
| 125965722 | 12596572 | 13 | SS | NAVELBINE | VINORELBINE TARTRATE | 1 | Intravenous drip | U | 0 | 30 | MG | ||||||||
| 125965722 | 12596572 | 14 | C | AROMASIN | EXEMESTANE | 1 | Oral | 0 | 25 | MG | |||||||||
| 125965722 | 12596572 | 15 | C | XELODA | CAPECITABINE | 1 | Oral | 0 | 1800 | MG | TABLET | ||||||||
| 125965722 | 12596572 | 16 | C | XELODA | CAPECITABINE | 1 | Oral | 0 | 1800 | MG | TABLET | ||||||||
| 125965722 | 12596572 | 17 | C | TYKERB | LAPATINIB DITOSYLATE | 1 | Oral | 0 | 1250 | MG | |||||||||
| 125965722 | 12596572 | 18 | C | DOCETAXEL. | DOCETAXEL | 1 | Intravenous drip | 0 | 60 | MG | |||||||||
| 125965722 | 12596572 | 19 | C | GEMZAR | GEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | 0 | 1000 | MG | |||||||||
| 125965722 | 12596572 | 20 | C | TULOBUTEROL | TULOBUTEROL | 1 | Transdermal | 0 | 2 | MG | QD | ||||||||
| 125965722 | 12596572 | 21 | C | AMBROXOL HYDROCHLORIDE | AMBROXOL HYDROCHLORIDE | 1 | Oral | 0 | 2 | DF | TABLET | BID | |||||||
| 125965722 | 12596572 | 22 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | 1 | DF | CAPSULE | QD | |||||||
| 125965722 | 12596572 | 23 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 125965722 | 12596572 | 24 | C | FLUTIDE DISKUS | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 0 | BID | ||||||||||
| 125965722 | 12596572 | 25 | C | THEO-DUR | THEOPHYLLINE ANHYDROUS | 1 | Oral | 0 | 3 | DF | TABLET | TID | |||||||
| 125965722 | 12596572 | 26 | C | ACTONEL | RISEDRONATE SODIUM | 1 | Oral | 0 | 1 | DF | TABLET | /wk | |||||||
| 125965722 | 12596572 | 27 | C | BUFFERIN TABLETS (JAPAN) | 2 | Oral | 0 | 1 | DF | TABLET | QD | ||||||||
| 125965722 | 12596572 | 28 | C | TEPRENONE | TEPRENONE | 1 | Oral | 0 | 1 | DF | CAPSULE | QD | |||||||
| 125965722 | 12596572 | 29 | C | THYRADIN | LEVOTHYROXINE | 1 | Oral | 0 | 2 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125965722 | 12596572 | 1 | Breast cancer |
| 125965722 | 12596572 | 4 | Breast cancer |
| 125965722 | 12596572 | 5 | Breast cancer |
| 125965722 | 12596572 | 6 | Breast cancer |
| 125965722 | 12596572 | 7 | Breast cancer |
| 125965722 | 12596572 | 8 | Breast cancer |
| 125965722 | 12596572 | 9 | Breast cancer |
| 125965722 | 12596572 | 10 | Breast cancer |
| 125965722 | 12596572 | 12 | Breast cancer |
| 125965722 | 12596572 | 13 | Breast cancer |
| 125965722 | 12596572 | 14 | Breast cancer |
| 125965722 | 12596572 | 15 | Breast cancer |
| 125965722 | 12596572 | 16 | Breast cancer |
| 125965722 | 12596572 | 17 | Breast cancer |
| 125965722 | 12596572 | 18 | Breast cancer |
| 125965722 | 12596572 | 19 | Breast cancer |
| 125965722 | 12596572 | 20 | Asthma |
| 125965722 | 12596572 | 21 | Asthma |
| 125965722 | 12596572 | 22 | Gastritis |
| 125965722 | 12596572 | 23 | Asthma |
| 125965722 | 12596572 | 24 | Asthma |
| 125965722 | 12596572 | 25 | Asthma |
| 125965722 | 12596572 | 26 | Osteoporosis |
| 125965722 | 12596572 | 28 | Gastritis |
| 125965722 | 12596572 | 29 | Hypothyroidism |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125965722 | 12596572 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125965722 | 12596572 | Anaphylactic reaction | |
| 125965722 | 12596572 | Febrile neutropenia | |
| 125965722 | 12596572 | Interstitial lung disease | |
| 125965722 | 12596572 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125965722 | 12596572 | 1 | 20140218 | 20140603 | 0 | |
| 125965722 | 12596572 | 2 | 20160315 | 0 | ||
| 125965722 | 12596572 | 3 | 20160621 | 0 | ||
| 125965722 | 12596572 | 4 | 20090219 | 20090219 | 0 | |
| 125965722 | 12596572 | 5 | 20090226 | 20091214 | 0 | |
| 125965722 | 12596572 | 6 | 20091215 | 20100108 | 0 | |
| 125965722 | 12596572 | 7 | 20100109 | 20100628 | 0 | |
| 125965722 | 12596572 | 8 | 20110301 | 20110804 | 0 | |
| 125965722 | 12596572 | 9 | 20110805 | 20120813 | 0 | |
| 125965722 | 12596572 | 10 | 20120814 | 20140217 | 0 | |
| 125965722 | 12596572 | 11 | 20120814 | 20140217 | 0 | |
| 125965722 | 12596572 | 12 | 20091215 | 0 | ||
| 125965722 | 12596572 | 13 | 20100109 | 20100628 | 0 | |
| 125965722 | 12596572 | 14 | 20090219 | 20091214 | 0 | |
| 125965722 | 12596572 | 15 | 20100629 | 20110228 | 0 | |
| 125965722 | 12596572 | 16 | 20110301 | 20110804 | 0 | |
| 125965722 | 12596572 | 17 | 20100629 | 20110228 | 0 | |
| 125965722 | 12596572 | 18 | 20110805 | 20120813 | 0 | |
| 125965722 | 12596572 | 19 | 20120814 | 20140217 | 0 |